Oligometastatic non-small-cell lung cancer: current treatment strategies
Patrick J Richard, Ramesh Rengan Department of Radiation Oncology, University of Washington, Seattle, WA, USA Abstract: The oligometastatic disease theory was initially described in 1995 by Hellman and Weichselbaum. Since then, much work has been performed to investigate its existence in ma...
Guardado en:
Autores principales: | Richard PJ, Rengan R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12604e078d974966b21aec69246fa09b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oligoprogression in Non-Small Cell Lung Cancer
por: Daijiro Harada, et al.
Publicado: (2021) -
Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: David L. Billing, et al.
Publicado: (2021) -
SABR in oligometastatic breast cancer: Current status and future directions
por: Rachel Stewart, et al.
Publicado: (2021) -
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Yilin Cao, et al.
Publicado: (2021) -
Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Danyang Zhou, et al.
Publicado: (2021)